Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan

NCT06527846 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT06527846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06527846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients With Chronic Kidney Disease in Japan
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Active, not recruiting
Start date
October 22, 2024
Completion date
March 31, 2027
Enrollment
1,024 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney disease, chronic